We emphasize 'portfolio’ because relying on one or a few stocks is inherently risky, no matter how strong the fundamentals ...

Eli Lilly's oral GLP-1 drug orforglipron showed strong Phase 3 results with 7.9% weight loss and good tolerability, ...

Crocs‘ (NASDAQ: CROX) shares are down 18% in 2025, underperforming the S&P 500’s 8% decline, as uneven brand performance has ...

Delta Air Lines posted solid earnings for Q1 2025, surpassing analyst EPS estimates, though it fell short of management's ambitious projections.

Operating margins for the March quarter expanded 110 basis points to 17.5 per cent from 16.4 per cent in the corresponding ...

Navitas Semiconductor's revenue grew 5% 2024. The stock price declined in response, and is now near a record low. See why I would rate NVTS a Strong Buy today.